We recently published a list of Coatue’s 35 Most Important AI Stocks. In this article, we are going to take a look at where NVIDIA Corporation (NASDAQ:NVDA) stands against Coatue’s other most important AI stocks.

Morgan Stanley is also very bullish on the growth prospects for humanoid robots. The investment banking firm forecasts that there will be 40,000 humanoids working alongside humans in the U.S. by 2030, and that number will soar to 8 million by 2040 and 63 million by 2050.

Nvidia stock shed 17% on Monday and erased $589 billion from its market cap, the worst single-day loss of market value ever, amid panic over DeepSeek.

The recovery came after US chipmaker Nvidia closed up 9 per cent on Tuesday, recouping some of the heavy losses that wiped $600bn off its market capitalisation at the start of the week, when investors fretted over the threat from China’s DeepSeek to the US supremacy in artificial intelligence.

We recently compiled a list of the Goldman Sachs’ 35 AI Superstars. In this article, we are going to take a look at where Equinix, Inc. (NASDAQ:EQIX) stands against the other AI stocks. In September 2024,

A Chinese artificial intelligence company called DeepSeek is grabbing America's attention — and sending a shock wave through Wall Street — due to its new tech, which some experts say rivals that of OpenAI's ChatGPT.

On Wednesday, Goldman Sachs GS-0.41%decrease; red down pointing triangle, JPMorgan, Wells Fargo and Citigroup all posted profits that were better than expected. Similar readings came from others ...

The equity market's drop, triggered by DeepSeek’s R1 LLM model news, was a correction and not the start of a sustained bear market, he said in a note. Goldman analysts continue to be confident about global economic growth and see U.

Importantly, several Wall Street analysts have updated or reiterated their forecasts since DeepSeek published its research paper last week, and they all see upside in Nvidia stock from its current price of $128 per share. Joseph Moore at Morgan Stanley set his target price at $152 per share, implying a 18% upside.

This pharma stock has made strong gains over the past 12 months thanks to its strong earnings. Now it is testing a fresh buy point.

We recently compiled a list of the Goldman Sachs’ 35 AI Superstars. In this article, we are going to take a look at where Super Micro Computer, Inc. (NASDAQ:SMCI) stands against the other AI stocks. In September 2024,

We recently published a list of 35 Non-Tech AI Opportunities Amid DeepSeek Selloff. In this article, we are going to take a look at where R1 RCM Inc.